Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease

American Journal of Medicine

Volumn 129, Issue 5, 2016, Pages e35-e36

  Raju, Nina ^a   Sobieraj Teague, Magdalena ^b   Bosch, Jackie ^c   Eikelboom, John W ^c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LETTER; META ANALYSIS (TOPIC); MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION;

ASPIRIN; CARDIOVASCULAR DISEASES; HUMANS; PRIMARY PREVENTION;

EID: 84965168651     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.10.046     Document Type: Letter

References (2)

1. N. Raju, M. Sobieraj-Teague, J. Hirsh, and et al. Effect of aspirin on mortality in the prevention of cardiovascular disease Am J Med 124 2011 621 629
2. Y. Ikeda, K. Shimada, T. Teramoto, and et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors JAMA 312 2014 2510 2520